If you find yourself needing senna or Dulcolax daily on semaglutide, talk to your prescriber
NAD+ handles the quality of your GLP-1 experience energy, clarity, recovery, skin
Michael Lincoff, Professor of Medicine at Cleveland Clinic and the lead study author of the SELECT outcomes trial
Key differential aspects of the group of glucagon-like peptide-1 receptor agonist drugs There are several arGLP-1 s approved or under study for the use in DM2: exenatide (exenatide and exenatide LAR or weekly), liraglutide, lixisenatide, dulaglutide, semaglutide, albiglutide (withdrawn from the market), and efpeglenatide (in clinical development)
As weight-loss treatments continue to evolve, two medications are leading the conversation: Retatrutide and Mounjaro (tirzepatide)
Further, GLP-1RA therapy was associated with reduced risks of stroke or TIA, MI, VTE, PE, all-cause mortality, hospitalization, and ED visits in participants with T2D